Skip to content

Clinical Comparison of Octanidine and Chlorhexidine based Mouthrince

Clinical Comparison of Octanidine and Chlorhexidine based Mouth rinses as an adjunct in post-periodontal flap Surgery Healing- A randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096091
Enrollment
20
Registered
2025-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: .1 % Octanidine mouthwash: Post surgical/open flap debridement mouth riinsing Twice daily For 14 days Control Intervention1: .1% chlorhexidine mouthwash: post surgical /open flap debrid

Sponsors

Dr David K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patient who are indicated for periodontal flap surgery (2) Systemically healthy older than 18 years (3) With basic communication, reading and writing skills (4) Willingness to sign an informed consent form

Exclusion criteria

Exclusion criteria: (1) Surgeries other than periodontal flap surgery (2) Systematic diseases and psychological or medical disorders that might influence pain threshold (5) acute intraoral pain (periodontal or endodontic pain) (6) Hypersensitivity to the mouthwash ingredients

Design outcomes

Primary

MeasureTime frame
1.To evaluate wound healing outcomes following the use of .1 % Octanidine mouthwash post-periodontal flap surgery on days 3, 7, and 14 utilizing the wound healing index, 2.To evaluate wound healing outcomes following the use of .12% chlorhexidine mouthwash post-periodontal flap surgery on days 3, 7, and 14 days using wound healing index. 3 To conduct both intergroup and intragroup comparisons of the outcomes. Timepoint: 3, 7, 14 days

Secondary

MeasureTime frame
To evaluate the PROM (patient reported outcome measures) among both the groups using Visual analogue scale and analgesic intake Timepoint: 3,7 ,14 days

Countries

India

Contacts

Public ContactDr David K

manipal college of dental sciences ,mangalore

david.k@manipal.edu09611362034

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026